Paying users zone. Data is hidden behind 
.
Get 1-month access to Biogen Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Biogen Inc. (NASDAQ:BIIB)
Adjustments to Financial Statements
Advanced level
Adjustments to Current Assets
Biogen Inc., adjusted current assets
US$ in thousands
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current assets | ||||||
| Adjustments | ||||||
| Add: Reserves for allowances | ||||||
| After Adjustment | ||||||
| Adjusted current assets | ||||||
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
Adjustments to Total Assets
Biogen Inc., adjusted total assets
US$ in thousands
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »
2 Deferred tax asset. See details »
Adjustments to Current Liabilities
Biogen Inc., adjusted current liabilities
US$ in thousands
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current liabilities | ||||||
| Adjustments | ||||||
| Less: Current restructuring reserve | ||||||
| After Adjustment | ||||||
| Adjusted current liabilities | ||||||
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
Adjustments to Total Liabilities
Biogen Inc., adjusted total liabilities
US$ in thousands
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Deferred tax liability. See details »
Adjustments to Stockholders’ Equity
Biogen Inc., adjusted total Biogen Inc. shareholders’ equity
US$ in thousands
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
1 Deferred tax assets and liabilities, net. See details »
Adjustments to Capitalization Table
Biogen Inc., adjusted capitalization table
US$ in thousands
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Current operating lease liabilities (included in Accrued expenses and other). See details »
3 Long-term operating lease liabilities. See details »
4 Deferred tax assets and liabilities, net. See details »
Adjustments to Reported Income
Biogen Inc., adjusted net income attributable to Biogen Inc.
US$ in thousands
Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03).
1 Deferred income tax expense (benefit). See details »